Sunshine Biopharma (SBFM) Debt Ratio (2017 - 2021)

Sunshine Biopharma has reported Debt Ratio for 5 years, with the latest figure at 0.86 in Q4 2021.

• For the quarter ending Q4 2021, Debt Ratio fell 4.98% year-over-year to 0.86; the trailing twelve-month figure through Dec 2021 stood at 0.86 (down 4.98% YoY), and the FY2021 full-year result was 0.86, down 4.98% from the prior year.
• Debt Ratio for Q4 2021 stood at 0.86, down from 1.28 in the prior quarter.
• The five-year high for Debt Ratio was 1.28 in Q3 2021, with the low at 0.19 in Q3 2019.
• Historically, Debt Ratio has averaged 0.61 across 5 years, with a median of 0.46 in 2020.
• Annual changes were most pronounced in 2018 — Debt Ratio fell 12.46% — and 2020, when it surged 245.09%.
• Sunshine Biopharma's Debt Ratio stood at 0.31 in 2017, then slipped by 12.46% to 0.27 in 2018, then plunged by 30.55% to 0.19 in 2019, then surged by 382.31% to 0.91 in 2020, then declined by 4.98% to 0.86 in 2021.
• The last three Debt Ratio figures came in at 0.86 (Q4 2021), 1.28 (Q3 2021), and 1.13 (Q2 2021), per Business Quant data.